Analysts expect sales decline Biogen

Tomorrow Biogen will publish its past quarters results. Over the current book year the total revenu from the company based in Cambridge will be 10.64 billion USD (consensus estimates). This is rather significant lower than 2021's revenue of 13.44 billion USD.

Historical revenues and results Biogen plus estimates 2021

The analysts expect for 2021 a net profit of 2.82 billion USD. The majority of the analysts expects for this year a profit per share of 18.62 USD. The price-earnings-ratio equals 17.32.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals an attractive1.97 percent.

Biogen 's market capitalization is based on the number of outstanding shares around 56.18 billion USD. 15

Historical stock prices Biogen2007-2021

On Tuesday the stock closed at 322.49 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.